Studies with Novel Pdr5p Substrates Demonstrate a Strong Size Dependence for Xenobiotic Efflux
Open Access
- 1 February 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (8), 5963-5969
- https://doi.org/10.1074/jbc.m210908200
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pancreas Cell Physiology and Pancreatitis Cell BiologyPancreatology, 2003
- Doxycycline Induces Expression of P Glycoprotein in MCF-7 Breast Carcinoma CellsAntimicrobial Agents and Chemotherapy, 2002
- Determining the Dimensions of the Drug-binding Domain of Human P-glycoprotein Using Thiol Cross-linking Compounds as Molecular RulersJournal of Biological Chemistry, 2001
- Structure–activity relationship of P-glycoprotein substrates and modifiersEuropean Journal of Pharmaceutical Sciences, 2000
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Radical cyclisation onto imidazoles and benzimidazolesTetrahedron, 1999
- Genetic Separation of FK506 Susceptibility and Drug Transport in the Yeast Pdr5 ATP-binding Cassette Multidrug Resistance TransporterMolecular Biology of the Cell, 1998
- Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5pPublished by Elsevier BV ,1996
- Loss of function mutation in the yeast multiple drug resistance gene PDR5 causes a reduction in chloramphenicol effluxAntimicrobial Agents and Chemotherapy, 1994
- Transcriptional control of the yeast PDR5 gene by the PDR3 gene product.Molecular and Cellular Biology, 1994